RAG1 and neoplasm: Accordingly, RAG1-/- mice bearing established subcutaneous B16-F10 tumors were injected intratumorally (i.t.)with vMyx-IL15Rα-tdTr, vMyx-tdTr or PBS on days 7 and 10 post tumor cell injection.